Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/F/TAF) After Renal Transplant

Clinical trial NCT04530630 · COMPLETED

Trial details

NCT number: NCT04530630
Sponsor: Weill Medical College of Cornell University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

HIV Infections Renal Transplant Rejection

Start date: 2020-11-09
Primary completion: 2024-08-28
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.